Fredrik Steen

Fredrik Steen (6 September 1895 – 22 October 1970) was a Norwegian pharmacist and businessperson.

He was a son of Emil Steen and Laura Steen.[1] He was a grandson of Emil Steen (1829–1884), a nephew of Johan and Christian Steen and a first cousin of Erling Steen.[2][3]

Several family members were owners of Steen & Strøm, but Fredrik Steen's father had become a partner in the pharmaceutical wholesaling company Nyegaard & Co. His father was the sole owner of this company from 1913, and transformed it from a wholesaling company to a manufacturer of pharmaceutical products.[4] However, he died in 1915. Fredrik's mother Laura ran the company until 1921, when Fredrik took over. He orchestrated a merger with Koren & Gedde and brought that company's owner Sverre Blix on board as co-owner.[1]

Fredrik Steen had taken the cand.pharm. degree in 1916, and been an assistant at the Royal Frederick University. By 1921 he was the manager of both Nyegaard & Co and Koren & Gedde, and alternated every second year with Sverre Blix in being chairman of the board of Nyegaard & Co. He was also a board member of Koren & Gedde and A/S Para.[5] Steen retired in 1960.[6]

He was a vice chairman of Norsk Farmaceutisk Selskap. He was also involved in dog breeding, most specifically of English setters.[6] He died in October 1970.[2]

References

  1. 1 2 "Norsk legemiddelindutris eventyrlige utvikling". Aftenposten. 25 November 1949. p. 7.
  2. 1 2 "Dødsfall". Aftenposten. 21 July 1915. p. 3.
  3. ↑ Boye, Else. "Johan Steen". In Helle, Knut. Norsk biografisk leksikon (in Norwegian). Oslo: Kunnskapsforlaget. Retrieved 18 December 2011.
  4. ↑ "50-aars forretningsjubilæum. Nyegaard & Co.". Aftenposten. 27 August 1924. p. 4.
  5. ↑ Hoffstad, Einar, ed. (1935). "Steen, Fr(edrik)". Merkantilt biografisk leksikon (in Norwegian) (1st ed.). Oslo: Yrkesforlaget. p. 716. Retrieved 23 December 2011.
  6. 1 2 "Direktør Fredrik Steen 70 år". Aftenposten. 4 September 1965. p. 10.


This article is issued from Wikipedia - version of the 5/19/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.